Enterococci present a serious problem in hospitals, especially in the USA, where in intensive care and transplantation units as many as 15% of the strains are resistant to vancomycin. In Europe the situation with regard to vancomycin resistance in clinical isolates is better, usually with sporadic cases in intensive care and hematology units [l-31. O n the other hand, enterococci with various level of vancomycin resistance have been found colonizing the feces of healthy individuals in different parts of Europe [4, 5] .
In Greece, there have so far been very few reports of vancomycin-resistant enterococci (VRE) , possibly because of the strict policy for vancomycin use that was established early enough in most hospitals by the infection control committees. We report a case of intraabdominal infection with an Enterococnrs faecium VanB isolate in a patient with Prader-Willy syndrome and acute pancreatitis.
A 14-year-old Caucasian boy was admitted to the emergency room of our hospital for acute abdominal pain 6 h before, dyspnea, high fever and a low consciousness level. Physical examination revealed fever (40.5OC), acute abdominal pain and tenderness in the right part of the abdomen, which reflected to the right kidney area. Laboratory results showed a leukocyte count of 29 600/mm3 (80% neutrophils), hematocrit 48.2%, glucose 435 mg/dL (normal range 65-125), SGOT 760 IU/L (5-45), SGPT 410 IU/L (5-45), amylase 240 IU/L (0-220), and lactate dehydrogenase (LDH) 960 IU/L (0-450). Blood gases revealed metabolic acidosis (PO2 76, pCO2 27.5 and pH 7.45). Chest X-ray was normal, and abdominal ultrasound scanning, pedormed with great difficulty (due to excess weight), showed liquid in the peritoneal cavity.
The boy had had a known Prader-Wily syndrome since birth (mental deficiency, great obesity, increased appetite with ability to consume huge quantities of food, sexual infantilism and peripheral muscular atony).
He also had a history of acute pancreatitis episodes. The boy was living in Bulgaria and the family had very recently moved to Greece as migrants.
The patient was admitted to the internal medicine department but was immediately transferred to the intensive care unit (ICU) because of septic shock with spasms and acute dyspnea. He was immediately started on antimicrobial treatment with amikacin and cehiaxone; this was changed to meropenem, fluconazole and ornidazole after 5 days, and again to cef'tazidime, fluconazole and ornidazole after 6 more days. His general condition remained the same, and high fever continued. A CT scan was performed with better preparation, and this time revealed a cyst in the proximity of the pancreatic body, fluid in the peritoneal cavity and fluid in the pleural space. Surgery revealed an abscess in the proximity of the head and the body of the pancreas; t h s was removed and the area was cleaned. The antimicrobial treatment was changed to co-trimoxazole, piperacillin+ tazobactam and fluconazole. The cultures h m the abscess were negative, as were all the blood cultures taken so far.
A s m a l l improvement in the patient's general condition was observed which lasted for 6 days. O n the 28th hospital day, fever rose again and his general condition deteriorated. Treatment was changed again, to ciprofloxacin, vancomycin and fluconazole, with no results. A culture specimen was taken h m the drainage on the 36th day, and revealed Pseudomonas aeruginosa and Enterococnrs spp. The treatment was changed to imipenem and fluconazole. Another set of blood cultures was negative.
O n the 40th hospitalization day, the patient was reoperated on but died during the surgical procedure as a result of oligemic shock.
The Figure 1 ). For quality control, the strains E. faecium BM4147 (lane 2 in Figure l) , which harbored the vanA gene, and E. fuectllis V583 (lane 3 in Figure l) In Greece, up to now, there has been no sigdcant vancomycin resistance. In both local and multicenter studies [10, 11] , the frequency of VRE clinical isolates was never higher than 1%. with the exception of one study [12] fbm northern Greece, which presented a rate of 7.6%. This rate changed to 0% 2 years later in the same institution [13] . In our hospital, surveillance using the WHONET software has never maled, until now, a VRE strain [14] , and the isolate under discussion was the first one with vancomycin resistance. To our knowledge, it is also the first fully characterized VanB E. faecium clinical isolate found in Greece.
The isolate was considered to be a colonizer rather than a true pathogen, since it was isolated fhm abdominal drainage only. Colonization was possibly the result of prolonged antibiotic use, especially vancomycin, or of VRE spread fhm patient to patient via the hands of personnel or various equipment. At the time of isolation, there was no screening program for V I U in patient fecal flora in the ICU, so we did not have the opportunity to screen the patient after the isolation because of his rapid deterioration and death.
Immediately after isolation of the first VRE, a rectal culture surveillance program was started which is currently being carried out in all patients of the ICU and certain other departments of the hospital. 
